EE329 Budget Impact Analysis of Adding Risankizumab and Upadacitinib for the Treatment of Inflammatory Bowel Disease in the Kingdom of Saudi Arabia

Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.595
https://www.valueinhealthjournal.com/article/S1098-3015(23)03725-7/fulltext
Section Title :
Section Order : 10087
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03725-7&doi=10.1016/j.jval.2023.09.595
HEOR Topics :
Tags :
Regions :